Analysis of Particle Deposition in the Turbinate and Olfactory Regions Using a Human Nasal Computational Fluid Dynamics Model
- 1 September 2006
- journal article
- Published by SAGE Publications in Journal of Aerosol Medicine
- Vol. 19 (3) , 301-313
Abstract
The human nasal passages effectively filter particles from inhaled air. This prevents harmful pollutants from reaching susceptible pulmonary airways, but may leave the nasal mucosa vulnerable to potentially injurious effects from inhaled toxicants. This filtering property may also be strategically used for aerosolized nasal drug delivery. The nasal route has recently been considered as a means of delivering systemically acting drugs due to the large absorptive surface area available in close proximity to the nostrils. In this study, a computational fluid dynamics (CFD) model of nasal airflow was used with a particle transport and deposition code to predict localized deposition of inhaled particles in human nasal passages. The model geometry was formed from MRI scan tracings of the nasal passages of a healthy adult male. Spherical particles ranging in size from 5 to 50 microm were released from the nostrils. Particle trajectories and deposition sites were calculated in the presence of steady-state inspiratory airflow at volumetric flow rates of 7.5, 15, and 30 L/min. The nasal valve, turbinates, and olfactory region were defined in the CFD model so that particles depositing in these regions could be identified and correlated with their release positions on the nostril surfaces. When plotted against impaction parameter, deposition efficiencies in these regions exhibited maximum values of 53%, 20%, and 3%, respectively. Analysis of preferential deposition patterns and nostril release positions under natural breathing scenarios can be used to determine optimal particle size and flow rate combinations to selectively target drug particles to specific regions of the nose.Keywords
This publication has 26 references indexed in Scilit:
- Drug Delivery to the Nasal Cavity: In Vitro and In Vivo AssessmentCritical Reviews™ in Therapeutic Drug Carrier Systems, 2004
- Nasal drug delivery—possibilities, problems and solutionsJournal of Controlled Release, 2003
- Nasal drug delivery: new developments and strategiesDrug Discovery Today, 2002
- Drug Transport into the Mammalian Brain: The Nasal Pathway and its Specific Metabolic BarrierJournal of Drug Targeting, 2002
- Preliminary Study of the Deposition of Aerosol in the Maxillary Sinuses Using a Plastinated ModelJournal of Aerosol Medicine, 2001
- Health Risks Associated with Inhaled Nasal ToxicantsCritical Reviews in Toxicology, 2001
- The Effect of Nasal Passage Characteristics on Particle DepositionJournal of Aerosol Medicine, 1998
- Increased Incidence of DNA Double-Strand Breaks in Lung and Liver of Rats After Exposure to Crocidolite Asbestos FibersInhalation Toxicology, 1994
- Inspiratory Inertial Deposition of Aerosols in Human Nasal Airway Replicate Casts: Implication for the Proposed NCRP Lung ModelRadiation Protection Dosimetry, 1991
- The deposition of aerosol particles in the nasopharyngeal region of the human respiratory tractJournal of Aerosol Science, 1971